CLOV

Clover Health Investments Co

-$84.2M

Net Activity

Institutions Holding

208

Popularity Rank

#2788

Avg Weight

0.00%

Total Value

$236.5M

Ownership Trend

208 institutions currently hold CLOV, with 95 net buyers and 84 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

84

Net Buying Institutions

95

Key Holders

View all 208 holding institutions

Quarterly Activity

Recent Activity

+$94.6M

Total Buy Value

$161.6M

Total Sell Value

New buy37
Trim56
Add58
Sold out28

95

Net Buyers

84

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

9

Filings (90d)

$1.91M

Total Est. Value

360K shares

Planned Shares

Last Filed 2026-07-17
FilerFiling DateEst. Value
JAMIE REYNOSO2026-07-17$21K
JAMIE REYNOSO2026-07-08$12K
Jamie Reynoso2026-07-06$33K
Andrew Toy2026-07-01$1.67M
Reynoso Jamie L.2026-06-17$12K
OLDAKOWSKI JOSEPH FRANK2026-06-16$70K
Reynoso Jamie L.2026-06-15$36K
Soares Karen2026-06-15$26K
Reynoso Jamie L.2026-06-11$36K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-07-17

View all Form 8-K filings

FAQ

Who are the top institutional investors holding CLOVER HEALTH INVESTMENTS CO (CLOV)?
Major stakeholders currently include BlackRock, Inc. ($56.0M), Vanguard Capital Management LLC ($29.9M), Geode Capital Management, LLC ($17.7M). Based on the latest 13F filings, there are a total of 208 tracked investment funds and institutions maintaining positions in CLOV.
What is the overall institutional sentiment toward CLOV recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $84.2M, driven by 95 managers accumulating shares while 84 reduced their exposure.
Which institutions have been selling or reducing their CLOV positions?
In the latest period, 56 funds trimmed their holdings, and 28 managers completely exited their positions. The aggregate reported sell value was $161.6M.
Are there any notable investors adding CLOV to their portfolios?
Yes, buying activity remains notable. 37 institutions opened new positions in {ticker}, and 58 existing holders added to their shares. The total reported buy value for the quarter amounted to $94.6M.

Related Stocks